Smartleaf Asset Management »

Celldex Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.7k 291 26.43
2025-09-30 $1.4k 52 26.17
2025-06-30 $141 7 20.29
2024-12-31 $7.6k 303 25.12
2024-09-30 $6.3k 190 33.20
2024-06-30 $1.1k 28 37.68

More positions owned by Smartleaf Asset Management

Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Smartleaf Asset Management

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Commodore Capital
Deep Track Capital
Braidwell
Point72 Asset Management
Eventide Asset Management
Geode Capital Management
Eversept Partners
Novo A/S

View all funds holding Celldex Therapeutics